ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,320Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 134

$504K Total Retail Price of All Prescriptions

Rank: 35 out of 134

490 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 490 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 490 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 7,984 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
SIMVASTATIN 418 401 1 2
LEVOTHYROXINE SODIUM 327 315 2 1
LISINOPRIL 273 268 3 4
OMEPRAZOLE 248 233 4 3
LOSARTAN POTASSIUM 232 219 5 11
METOPROLOL SUCCINATE 218 218 6 16
ZOLPIDEM TARTRATE 204 197 7 15
CITALOPRAM HBR 180 176 8 14
AMLODIPINE BESYLATE 177 167 9 6
ATORVASTATIN CALCIUM 167 164 10 18
HYDROCODONE-ACETAMINOPHEN 165 146 S3 11 5
ALLOPURINOL 144 144 12 25
FUROSEMIDE 140 140 13 7
ADVAIR DISKUS 112 112 14 38
METOPROLOL TARTRATE 109 109 15 17
METFORMIN HCL 106 102 16 9
WARFARIN SODIUM 105 105 17 8
CRESTOR 100 100 18 39
FLUTICASONE PROPIONATE 98 90 19 34
PRAVASTATIN SODIUM 94 83 20 20
FINASTERIDE 92 92 21 85
SYNTHROID 91 91 22 56
LOVASTATIN 88 88 23 33
TRAMADOL HCL 84 82 24 22
SPIRONOLACTONE 84 84 24 29
TAMSULOSIN HCL 84 76 24 26
SPIRIVA 83 83 27 47
GABAPENTIN 75 68 28 12
DOXAZOSIN MESYLATE 69 69 29 68
DILTIAZEM ER 68 68 30 91
ALENDRONATE SODIUM 68 67 30 21
FLECAINIDE ACETATE 67 67 32 206
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 66 33 45
DIOVAN 65 65 34 55
HYDROCHLOROTHIAZIDE 62 62 35 13
POTASSIUM CHLORIDE 61 61 36 10
DIGOXIN 58 58 37 31
TRAZODONE HCL 54 53 38 23
PREDNISONE 54 53 38 28
LOSARTAN-HYDROCHLOROTHIAZIDE 53 53 40 50
VENLAFAXINE HCL 53 48 40 230
BENAZEPRIL HCL 52 52 42 89
MELOXICAM 51 48 43 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.